Studies were deemed eligible for inclusion in this systematic review if they investigated adult patients with type 2 diabetes mellitus (T2DM) and evaluated high-sensitivity cardiac troponin (hs-cTnT or hs-cTnI) as a predictor of long-term cardiovascular outcomes. Here, TNNI3 is linked to type 2 diabetes mellitus.